|
The Role of Tyrosine Kinase Inhibitors in the Treatment of Gastrointestinal Stromal Tumors
Mercredi 30 Juillet 2008 - 09:00 - 3 mois, 3 semaines depuis - Presse spécialisée - Medscape hematology oncology This comprehensive review explores the diagnosis and management of gastrointestinal stromal tumors, exploring the role of tyrosine kinase inhibitors and other novel treatment options in the management of this disease. Medscape Hematology-Oncology |
|
Rates of Mantle Cell Lymphoma are Steadily Rising
Mercredi 09 Juillet 2008 - 14:57 - 4 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology The incidence of mantle cell lymphoma increased between 1992 and 2004, with a significantly higher incidence in men, white Americans, and people older than 50 years. Most patients were diagnosed with stage 4 disease. Mortality rates also increased during this time period. Medscape Medical News |
|
Biomarkers Predict Risk for Prostate Cancer Recurrence
Mercredi 09 Juillet 2008 - 14:20 - 4 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology A blood test that screens for a panel of 7 biomarkers can accurately predict whether a patient will experience disease recurrence, researchers suggest. Medscape Medical News |
|
Study Identifies Unique Biology of Breast Cancers Arising in Younger Women
Mercredi 09 Juillet 2008 - 13:51 - 4 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology Lower hormone sensitivity and higher EGFR mRNA expression suggest poor outcome in younger women's breast cancers. Medscape Medical News |
|
Emerging Therapies for Melanoma
Mercredi 09 Juillet 2008 - 08:23 - 4 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology Treatments for melanoma have evolved to keep pace with improved understanding of cellular activity. This review summarizes what has taken place over the last five years. Expert Review of Anticancer Therapy |
|
Primary ADT Does Not Improve Survival in Prostate Cancer
Mercredi 09 Juillet 2008 - 07:34 - 4 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology Primary androgen-deprivation therapy, used instead of surgery and/or radiation, does not improve survival over conservative management. Medscape Medical News |
|
Effective Treatment of Pancreatic Cancer Remains Elusive
Mercredi 09 Juillet 2008 - 05:58 - 4 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology Developing effective therapies to treat pancreatic cancer remains a challenge, because many promising therapies have not done as well as expected. The trend toward targeted therapies, however, offers promise for the future. Medscape Medical News |
|
The Role of Second-line Chemotherapy After Gemcitabine Failure in Patients With Advanced Pancreatic Cancer
Mardi 08 Juillet 2008 - 12:42 - 4 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology What patients are likely to derive clinical benefit from second line and salvage chemotherapy in advanced pancreatic cancer? What have we learned from the existing data? Future Oncology |
|
Statins and Prostate Cancer Prevention: Where We Are Now, and Future Directions
Mardi 08 Juillet 2008 - 06:51 - 4 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology Do statins reduce the risk of prostate cancer? Find out how these widely prescribed drugs may be working as double agents. Nature Clinical Practice Urology |
|
Vaccine Shows No Benefit in Renal Cell Carcinoma
Lundi 07 Juillet 2008 - 14:11 - 4 mois, 2 semaines depuis - Presse spécialisée - Medscape hematology oncology The heat-shock protein peptide complex, which was showing promise in early study, has failed a phase 3 trial. Medscape Medical News |
< 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 20 – 21 – 22 – 23 – 24 – 25 – 26 – 27 – 28 >
Actus fournies par : Medscape Hematology-Oncology Headlines